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Abstract 
EFFICIENCY OF THE THERMAL JACKET"' ON THE DEUVERED 
TEMPERATURE OF PREWARMED CRYSTALLOID INTRAVENOUS 
FLUID 
Danny R. Bowen, BSN 
School of Allied Health Professions--Virginia Commonwealth University, 1989. 
Major Director: John T. Beeston, BS, CRNA 
A quasi-experimental research design was used to determine the 
relationship between the flow rate and the delivered temperature of prewarmed 
crystalloid intravenous solutions when using the Thermal Jacket111, an insulation 
device designed for intravenous fluid bags, as compared to a conventional blood 
warming apparatus. One control and three experimental groups were used. 
Fluids in Group 1 (control group), Group 2, and Group 4 were prewarmed 
in a microwave oven to 41.45 ± 1.05 ° C. Fluids in Group 3 were left near 
ambient room temperature and measured at 22.05 ± 0.45 ° C. Fluids in the 
control group were infused through a standard intravenous pump tubing, 270 em 
in length, using no temperature maintenance device. Fluids in Group 2 and 
Group 3 were delivered through a standard intravenous pump tubing connected 
to a blood warming coil which was immersed in a water bath blood warmer. The 
distance from the exit point of the blood warmer to the distal end of the infusion 
line measured 174 em. Fluids in Group 4 were placed in a Thermal Jacket111 and 
Vlll 
delivered through standard intravenous pump tubing. After a baseline 
measurement, temperatures were recorded for all groups at two sites at 10 minute 
intervals over a 60 minute period. One site was the lower portion of the IV 
solution bag, and the other site was a point 2 em from the distal end of the 
infusion set. Temperatures were measured at flow rates of 100, 250, 500, 750, 
and 1,000 ml/hr for each group. 
Analysis of variance showed a highly significant group effect on the 
delivered temperature. A Bonferroni multiple comparisons test indicated no 
statistically significant difference between the delivered temperatures of Group 3 
(room temperature fluid + blood warmer) and Group 4 (prewarmed fluid + 
Thermal Jacket"'). Group 2 (prewarmed fluid + blood warmer) showed a 
significantly higher delivered temperature (p_ < .05) than the other groups, and the 
control group (prewarmed + no temperature maintenance device) showed a 
significantly lower delivered temperature (12. < .05). Analysis of variance also 
showed a highly significant flow rate effect on delivered temperature. A 
Bonferroni multiple comparisons indicated a significant difference (12. < .05) 
between the flow rates of 100, 250, 500, and 750 ml/hr, with the higher flow rates 
resulting in higher delivered temperatures. There was no significant difference 
noted between the delivered temperatures at 750 and 1,000 ml/hr. 
The Thermal Jacket"', used with prewarmed intravenous fluids, was as 
effective as the conventional method of delivering warmed fluids. Also, within 
the range of flow rates studied, faster flow rates tended to yield a higher 
delivered temperature. 
Chapter One 
Introduction 
Humans, as homeothermic animals, regulate body temperature by balancing 
heat production with heat loss. This balance is controlled by centers in the 
hypothalamus. The body responds appropriately, under normal circumstances, to 
temperatures above and below the set-point, or "normal" temperature range of 
36.6-37.5 • C (Berne & Levy, 1983; Cabanac, 1975; Elder, 1984). When the 
body's core temperature rises above normal, it is considered to be hyperthermic; 
when it falls below normal, it is considered to be hypothermic. Hypothermia is 
further classified as mild (34-36.5 ·C), moderate (28-33.5 ·C), deep (17-27.5 ·C), 
or profound (4-16.5 ·C) (Elder, 1984). 
Hypothermia affects all body systems to some degree. Moderate to 
profound hypothermia depresses cardiovascular function as evidenced by changes 
in the blood pressure, pulse, and electrocardiogram. It also depresses the 
respiratory system and decreases the oxygen delivery to the peripheral tissues. 
The central nervous system is depressed to the point of unconsciousness and renal 
function is decreased to a degree which hinders clearance of toxic substances and 
metabolic waste. Enzyme and hormone activity are decreased as are normal 
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clotting mechanisms. This degree of multisystem dysfunction is normally avoided 
by appropriate physiological responses to hypothermia. 
There are several factors related to anesthesia and the operating room 
environment which could place every patient at risk for developing hypothermia. 
The first of these is that anesthetic agents themselves interfere with the body's 
normal response mechanisms to changes in temperature (Flacke, Flacke, Ryan, & 
Britt, 1983; Lanning, Skulberg, & Abyholm, 1986; Vale, 1973). Secondly, 
intravenous fluids and blood products are often infused near or below room 
temperature and contribute to hypothermia (Boyan & Howland, 1961, 1963; 
Norman, Ahmad, & Zeig, 1986). The third factor is that anesthetic gases are 
delivered cold and dry, leading to increased heat loss (Lilly, 1986; Yale, 1973). 
The fourth mechanism is that the modem operating room is typically maintained 
at an ambient temperature of 19-21 'C, which is well below body core 
temperature. This low temperature, coupled with the high air turnover, 
contributes significantly to the development of hypothermia (Holdcraft & Hall, 
1978; Lilly, 1986; Morris & Wilkey, 1970). Lastly, cold irrigation fluids are often 
instilled in open body cavities and increase the heat loss during surgery (Goldberg 
& Roe, 1966; Holdcraft & Hall, 1978). 
Because the operating room environment, surgical procedures, and 
anesthesia interventions potentially induce heat loss in many patients, the 
anesthetist must take certain measures to avoid the development of hypothermia, 
particularly in high risk patients. Anesthetists employ active and passive 
measures to prevent this heat loss. Passive means of preventing hypothermia 
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include increased ambient room temperature, liberal use of blankets and drapes, 
the use of a heat and moisture exchange unit in the anesthesia breathing circuit, 
and the use of warmed irrigation solutions (Elder, 1984; Goldberg, 1988; Haslam 
& Nielsen, 1986; Lilly, 1986; Morris, 1971; Morris & Wilkey, 1970; Roizen, 
L'Hornmedieu, Wylie, & Ota, 1980; Shanks, 1975). Active means of preventing 
hypothermia include warming-blankets, heated and humidified inspiratory gases, 
warm gastrointestinal or peritoneal irrigation, radiant heat sources, and 
extracorporeal heat exchange units. One must remember, however that all of 
these active means have inherent risks, complications, and inconveniences 
(Conahan, Williams, Apfelbaum, & Lecky, 1985; Fried, Satiani, & Zeeb, 1986; 
Goudsouzian, Morris, & Ryan, 1973; Harnett, Pruitt, & Sias, 1983; Morris & 
Kumar, 1972; Papenburg, English, Foot, Farias, & Hinchey, 1987; Pickering, 
Bristow, & Craig, 1977; Scott, 1967; Shanks, 1975; Stone, Downs, Paul, & Perkins, 
1981). Another popular active means of preventing hypothermia involves 
warming all intravenous infusions. This technique is effective when used alone or 
in combination with other methods (Boyan & Howland, 1961, 1962, 1963; 
Buckhold et al., 1978; Copping, Mather, & Winkler, 1972). Warming is 
accomplished by either the prewarrning of fluids or the infusion of fluids through 
devices designed to warm them immediately before administration. These blood 
warming devices, though cumbersome, are effective within certain ranges of 
infusion rates (Baker, 1985; Cooter, 1987; Ryrners, 1988). 
Prewarming fluids is effective only as long as the heat can be retained by 
the fluid prior to infusion. A new device has been developed which potentially 
increases the length of time that a bag of intravenous fluid retains its original 
prewarmed temperature without the use of bulky, cumbersome equipment. Its 
use with prewarmed fluids, therefore, may decrease both the incidence and 
severity of hypothermia in the operating room setting. This device, the Thermal 
Jacket'", is lightweight, easy to use, and potentially effective in infusing warmed 
fluids to the surgical patient. 
Statement 
of 
Purpose 
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The purpose of this study is to determine the relationship between the flow 
rate and the delivered temperature of prewarmed crystalloid intravenous solutions 
when using the Thermal Jacket'" as compared to a conventional blood warming 
apparatus. 
Statement of the Problem 
Is there a difference between the Thermal Jacket'", used with prewarmed 
intravenous fluids, and conventional warming methods in maintaining the 
delivered temperature of crystalloid solutions at various flow rates in the 
operating room environment? 
Hypotheses 
This study addresses the following hypotheses: 
1) there will be no difference between the delivered temperatures of 
prewarmed and room temperature fluids using a blood warmer apparatus; 
2) there will be no difference between the delivered temperatures of room 
temperature fluids using a blood warmer apparatus and prewarmed fluids using 
no temperature maintenance device; 
3) there will be no difference between the delivered temperatures of room 
temperature fluids using a blood warmer apparatus and prewarmed fluids using 
the Thermal Jacket"'; 
4) there will be no difference between the delivered temperatures of 
prewarmed fluids using a blood warmer apparatus when compared with no 
temperature maintenance device; 
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5) there will be no difference be.tween the delivered temperatures of 
prewarmed fluids using the Thermal Jacket"' when compared with no temperature 
maintenance device; and 
6) there will be no difference between the delivered temperatures of 
prewarmed fluids using the Thermal Jacket"' when compared with a blood 
warmer apparatus. 
Variables 
Independent. The independent variables were (a) the flow rate, and (b) the 
temperature maintenance device. 
Dependent. The dependent variable was the delivered temperature. 
Definition of Terms 
Flow rate. Flow rate is the volume of fluid delivered via an infusion pump 
expressed in milliliters per hour (ml/hr). Flow rates in this study ranged from 
100 ml/hr to 1,000 ml/hr. 
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Delivered temperature. Delivered temperature is the temperature of the 
fluid, expressed in degrees Celsius ( 0 C), at the distal end of the infusion tubing as 
measured by an inline thermistor. 
Prewarroed crystalloid solution. Prewarmed crystalloid solution is a 
commercially prepared intravenous solution containing no oncotically active 
substance. Crystalloid solution in this study refers to lactated Ringer's solution in 
1,000 milliliter (ml) bags warmed to approximately 42 ° C in a microwave oven. 
Thermal Jacket"'. The Thermal Jacket"' is an insulation device for 
intravenous fluid bags (Smith Medical Systems, Inc., Astoria, OR). 
Conventional blood warming apparatus. A conventional blood warming 
apparatus consists of a heated, fluid-filled, metal heat sink, an associated fluid 
warming coil immersed in the heated fluid, and a length of extension tubing 
connecting the coil in the heat sink to the patient's intravenous catheter. 
Assumptions 
1. All infusion pumps will deliver the rate of flow at which they are set. 
2. The thermometers will provide accurate readings of the temperature of 
the fluids. 
Limitations 
1. Five thermometers were used in this study. 
2. Four infusion pumps were used in this study. 
3. Room temperature was set using a wall thermostat and measured, but 
not controlled. 
Conceptual Framework 
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Thermore�lation. Homeothermic animals, such as humans, regulate their 
body temperatures by balancing heat production with heat loss. This balance 
involves a complex set of responses which have been only partially delineated. It 
is known that mechanisms such as autonomic and behavioral responses play a 
role in thermoregulation. It is also known that there are three components to 
thermoregulation. These components are the afferent temperature sensors, the 
efferent motor systems, and the control system. 
The mechanisms involved in thermoregulation can be described in terms of 
their responses to both increased and decreased body temperatures. The 
autonomic response to an increased temperature is stimulation of sweating and 
dilation of cutaneous blood vessels. Sweating increases heat loss by evaporation; 
and cutaneous vasodilation increases heat loss by radiation. Hormonal changes to 
increased temperature include a decrease in thyroxine release by the thyroid 
gland. This decrease reduces metabolism, which in turn decreases heat 
production. Behavioral responses to increased temperature include change of 
posture and avoidance of hostile temperatures. The change of posture serves to 
increase the surface to mass ratio, and thereby increases the heat exchange 
between the animal and the environment. 
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The autonomic response to a decreased temperature is piloerection and 
constriction of cutaneous blood vessels. Piloerection forms a layer of air dead 
space around the skin which decreases evaporative losses; and cutaneous 
vasoconstriction reduces radiant heat loss. The hormonal response to a decreased 
temperature is an increased output by the thyroid gland which increases 
metabolism and thereby increases heat production. Behavioral responses to 
decreased temperatures include a change of posture and avoidance of hostile 
temperatures. The change of posture with decreased temperatures serves to 
decrease the surface to mass ratio and decrease the heat exchange between the 
animal and the environment (Berne & Levy, 1983; Flacke et al., 1983; Cabanac, 
1975). 
As previously stated, there are three components to thermoregulation. Two 
of these, the afferent temperature sensors and the efferent motor systems, are 
regulated by the third, the control system. The afferent temperature sensors are 
divided into the peripheral sensors and the central sensors. It is estimated that 
the central sensors are three times more predominant than the peripheral sensors 
in humans (Cabanac, 1975). The most efficient responses to temperature 
changes, however, have been found to occur when both central and peripheral 
systems are intact (Downey, Miller, & Darling, 1969). The central sensors are 
located in the anterior hypothalamus and the spinal cord. The peripheral sensors 
are located nonuniformly in skin, mucosa, and some deep tissues. It has been 
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postulated that the uneven distribution of peripheral sensors suggests that 
weighted integrated input from the peripheral sensors exists which determines the 
sensitivity of the central regulatory system (Placke et al., 1983). This peripheral 
regulation of the central sensors may account for the observation that the most 
efficient responses occur when both systems are intact. The efferent motor 
systems include heat generating mechanisms such as skeletal muscle activity and 
heat dissipating mechanisms such as vasodilation. Although it is not the only 
contributor, the hypothalamus seems to be the center of thermoregulation (Berne 
& Levy, 1983; Cabanac, 1975). In addition to sensing temperature directly, it also 
receives input from the afferent system and regulates the efferent system to 
maintain a relatively constant temperature of 36.6-37.5 ° C. This set point 
temperature is the critical temperature above which heat dissipation is activated 
and below which heat generation and conservation are stimulated. 
Pathophysiolo� of hypothermia. Hypothermia has a number of detrimental 
effects on the normal physiology of the body. The cardiovascular, respiratory, 
nervous, renal, endocrine, and musculoskeletal systems are all adversely affected 
by hypothermia. These detrimental effects are a function of both the duration 
and the degree of hypothermia (Elder, 1984 ). 
The cardiovascular system is one of the major systems affected by 
hypothermia. With core temperatures ranging from 33-35 ° C, there is an 
increase in heart rate, central blood volume, and mean arterial blood pressure. 
Cardiac output can increase up to 500% due to peripheral vasoconstriction 
resulting from an increased level of catecholamines. At core temperatures of 30-
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33 ° C, there is a reflex decrease in heart rate, cardiac output, and blood pressure 
(Elder, 1984; Lonning et al., 1986). As the core temperature drops below 30 ° C, 
there is a propensity toward dysrhythmias. The electrocardiogram (ECG) 
demonstrates these dysrhythmias, as well as other characteristic electrical changes 
with an increasing magnitude of hypothermia. There are typically no changes, 
except in rate, noted on the ECG, at temperatures above 33 ° C. Below this core 
temperature there are increases in the P-Q and Q-T intervals, widening of the 
QRS complex, bradycardia, and development of a J-wave, all associated with a 
slowed myocardial conduction. There is also an increased likelihood of 
developing atrial fibrillation, atrial flutter, nodal rhythm, or second degree heart 
block. Below a core temperature of 30 ° C there is progressive widening of the 
QRS complex and extreme bradycardia with frequent occurrence of ventricular 
extrasystoles. Atrial fibrillation typically occurs due to atrial distention, and as 
the temperature continues to decrease, there is an increased incidence of more 
fatal dysrhythmias. Below 27-29 ° C there is a high incidence of ventricular 
fibrillation progressing to asystole at temperatures below 20 ° C (Churchill­
Davidson, 1955; Elder, 1984; Little, 1959; Lonning et al., 1986). 
The respiratory system also undergoes extreme changes in response to 
hypothermia. The initial response to core temperatures below 35 ° C is an 
increased respiratory rate corresponding to an increased oxygen demand caused 
by shivering. As the temperature falls below 33 ° C, there is a steady decrease in 
the respiratory rate, approaching 1-2 gasps per minute at temperatures below 
30 ° C. At these very low temperatures, there is an increased production of 
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bronchial secretions with an increased incidence of bronchospasm. Hypothermia 
shifts the oxyhemoglobin dissociation curve to the left, decreasing the release of 
oxygen from the hemoglobin molecule to the tissues. This effect on the 
oxyhemoglobin dissociation curve is offset, somewhat, by a shift to the right 
caused by metabolic acidosis. Metabolic acidosis accompanies the peripheral 
vasoconstriction seen with hypothermia. Functionally, then, the oxyhemoglobin 
dissociation curve changes have minimal consequences (Elder, 1984; Lilly, 1986; 
Little, 1959; Lonning et al., 1986). 
Other physiological systems show fewer, though no less profound, changes 
with hypothermia. The central nervous system shows mental impairment below 
33 ° C, progressing to a loss of consciousness below 30 ° C, and an absence of 
activity on the electroencephalogram (EEG) below 20 ° C (Elder, 1984; Little, 
1959; Lonning et al., 1986). The renal system demonstrates a "cold diuresis" 
between 33 ° C and 35 ° C due to the peripheral vasoconstriction associated with 
hypothermia. As the core temperature drops below 33 ° C, there is a decreased 
glomerular filtration rate which decreases the kidneys' ability to clear drugs and 
their metabolites (Elder, 1984; Lonning et al., 1986). With hypothermia comes 
hyperglycemia and ketosis due to a decreased release of insulin from the pancreas 
and a decreased insulin effect at the peripheral binding sites. There is also a 
decrease in overall enzyme activity, with the brain being more sensitive than 
other organs (Elder, 1984; Lonning et al., 1986). The musculoskeletal system 
responds to hypothermia with vasoconstriction and shivering. Below 33 ° C there 
is decreased shivering and a general stiffness of muscles and joints due to 
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muscular dysfunction as a result of impaired conduction in the peripheral nerves 
(Little, 1959; Lonning et al., 1986). There is a progressive prolongation of the 
clotting time, along with other coagulation defects, accompanying increased levels 
of hypothermia (Churchill-Davidson, 1955; Lonning et al., 1986). 
It is evident that as the degree of hypothermia increases, the degree of 
dysfunction in most systems of the body increases. Though some of these may 
be beneficial, the overall effect of hypothermia is a deleterious one which 
requires countermeasures to avoid eventual death. 
Hypothermia durin� anesthesia. Hypothermia during anesthesia and surgery 
is common. Two factors which contribute to intraoperative hypothermia are the 
nature of the operating theater environment and the effects of anesthesia on 
thermoregulation. There are four mechanisms for this heat loss in the 
anesthetized patient: (a) conduction, (b) convection, (c) radiation, and (d) 
evaporation. Conduction is the transfer of heat from the body to colder surfaces 
which it contacts. Convection is the heat loss to cooler, surrounding air currents 
and can be thought of as the wind chill factor. Radiation is the heat loss that 
occurs between objects of different temperatures not in contact with each other. 
The body radiates heat from uncovered areas, especially the scalp and upper 
torso. Evaporation is the loss that occurs when the skin and mucus membranes 
provide heat to transform liquid water to a gaseous state. 
The first factor contributing to intraoperative hypothermia is the operating 
room environment. The typical operating suite is conducive to heat loss leading 
to hypothermia. The ambient room temperature is commonly maintained at 19-
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21 ° C, primarily for the comfort of the surgical team. At those temperatures, 
without any measures taken to avoid heat loss, most patients will become 
hypothermic (Morris & Wilkey, 1970). Even at temperatures as high as 24 ° C, 
many patients still become hypothermic (Holdcraft & Hall, 1978; Lilly, 1986). 
Much of the heat loss can be accounted for solely by the ambient temperature. 
This is demonstrated by the greatest amount of heat loss occurring in the first 
hour in the operating room and in the time between skin closure and delivery to 
the recovery room. 
There are, however, factors other than room temperature that contribute to 
hypothermia. Modern operating rooms have a high air turnover which increases 
the likelihood of convective heat loss. The operating table, unless heated, will be 
near room temperature, and this increases the conductive heat loss. Irrigation 
fluids are frequently used at room temperature and this increases both conductive 
and convective heat loss. Another common factor is the increased surface area 
available for conductive, convective, and radiative heat losses when the integrity 
of the skin is interrupted by the surgeon's knife. All of these make the modern 
operating suite an ideal location for induction of unintentional hypothermia. 
The second factor contributing to intraoperative hypothermia is the effect of 
anesthetic agents on thermoregulation. While the operating room environment 
disrupts the balance of thermoregulation, anesthesia tips the scales in favor of 
hypothermia. Many of the anesthetic agents administered impair the 
compensatory mechanisms normally used by the body in thermoregulation. Many 
anesthetics cause cutaneous vasodilation, reduce thermogenic shivering, lower the 
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basal metabolic rate decreasing heat production, or act directly to impair the 
temperature regulation center in the hypothalamus (Flacke et al., 1983; Lonning 
et al., 1986; Yale, 1973). 
Even the intravenous fluids administered increase the risk of developing 
hypothermia. Intravenous fluids are usually infused at room temperature which 
may be almost 20 ° C lower than the core temperature of the body. Blood is 
typically infused at even lower temperatures. Blood is stored at 4-6 ° C and, 
other than incidental warming, is infused near that frigid temperature. Cold, dry 
anesthetic gases are administered to the patient which cause evaporative and 
convective heat loss (Lilly, 1986; Yale, 1973). The combination of anesthesia and 
operating theater environment set the scenario for a hypothermic patient, 
especially if that patient is already at risk for development of hypothermia. 
There are a number of patient characteristics which have been found to be 
related to an increased incidence of hypothermia. People at either extreme of 
age, namely young children and elderly adults, tend to have a higher incidence of 
hypothermia during anesthesia. The explanation for this, as well as an increased 
incidence of hypothermia in cachectic patients, seems to be related to decreased 
muscle mass, less vigorous shivering, and a resultant decrease in heat production. 
Patients with massive injuries, exhaustion, and undernourishment also have a 
decreased ability to produce heat; therefore, they have an increased risk of 
developing hypothermia (Lilly, 1986; Lonning et al., 1986; Roe, Goldberg, Blair, 
& Kinney, 1966). 
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There are also a number of characteristics associated with the surgery and 
surgical requirements that increase the incidence of hypothermia. Any procedure 
requiring the opening of any major body cavity increases the risk of hypothermia 
as does any procedure which necessitates infusion of large volumes of fluid or 
blood. (Goldberg & Roe, 1966; Lilly, 1986). As stated before, ambient 
temperature plays a major role in hypothermia, so any surgical condition which 
requires low ambient temperatures will put the patient at risk for heat loss. 
Patients who have substantial heat loss during surgery must regain this heat 
in the postoperative period. Unfortunately, those patients at increased risk for 
development of hypothermia are also those least capable of recovering the lost 
heat by increasing heat production in the postoperative period. For example, 
elderly patients have been found to require twice as much time to return to their 
preoperative temperatures when compared to younger adults, even though their 
immediate postoperative temperatures may be similar (Vaughn et al., 1981). 
Prevention of hwotherrnia. Since hypothermia in the operating room is 
quite common, a number of measures have been utilized to prevent or counter 
heat loss. These methods can be divided into two broad categories: passive and 
active warming. In the first of these, passive warming, the patient's endogenous 
heat production is the source of thermal energy and is augmented by decreasing 
the heat loss. Passive measures are typically easy to apply and have minimal risks 
associated with them. One passive method is to increase the ambient 
temperature at least until the patient is prepped and draped. At room 
temperatures above 24 · C very few patients will become hypothermic, whereas, at 
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temperatures below 21 ° C almost all patients become hypothermic (Morris, 1971; 
Morris & Wilkey, 1970; Roizen et al., 1980). Another passive method is covering 
as much of the patient as is practical with some type of insulating material. This 
material can be towels, cotton blankets, mylar-aluminum "space blankets", or even 
aluminum foil or plastic wrap. The most important areas to cover are the head, 
neck, and shoulders because these areas maintain perfusion even when the core 
temperature drops (Elder, 1984; Ully, 1986; Shanks, 1975). A third passive 
method of decreasing heat loss is the use of a heat-moisture exchange unit 
("artificial nose") inserted between the anesthesia breathing circuit and the 
endotracheal tube (Goldberg, et al., 1988; Haslam & Nielsen, 1986). This 
decreases the energy required to warm and humidify the cold, dry gases 
administered to the patient (Ully, 1986). The fourth passive method is the use of 
warmed irrigation solutions during surgery. These passive methods are relatively 
easy to employ, cost effective, and generally risk free. 
The second category of preventing or countering heat loss is active warming. 
With these measures, external energy is supplied to supplement the patient's own 
heat production. Active methods are usually more involved and potentially more 
dangerous than passive means. For example, the seemingly innocuous use of a 
warming-blanket can be hazardous. With warming blanket temperatures of 40-
42 ° C serious thermal injuries have been reported (Scott, 1967). 
Use of warming blankets is widespread in spite of studies which have shown 
them to be potentially dangerous as well as ineffective in preventing or reversing 
hypothermia in patients weighing more than 10 kg (Goudsouzian et al., 1973; 
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Morris & Kumar, 1972; Stone et al., 1981). Another active method, heating and 
humidifying of inspiratory gases, has been shown to be effective in preventing and 
even in reversing hypothermia (Conahan et al., 1985; Shanks, 1975; Stone et al., 
1981). This method, however, can cause thermal damage to the respiratory 
mucosa as well as potential overhydration due to the volume of fluid 
administered in the humidified gases via the breathing circuit (Harnett et al., 
1983). 
Gastrointestinal warming is another active method used to prevent or 
counter hypothermia. With this method, gastric lavage is accomplished with 
warm irrigation fluid. Gastrointestinal warming has the advantage of applying 
heat directly to the core of the body without penetrating any tissues. The only 
risk involved with this method is mechanical trauma from the insertion of the 
irrigation tube. 
A fourth method is the use of a radiant heat source. This is acceptable in 
the recovery room, but, because of the request from the surgical team for cooler 
ambient temperatures; this method is not practical except for infants (Flacke et 
al., 1983; Lilly, 1986). 
The fifth and sixth methods are peritoneal irrigation with warmed fluid and 
warming the patient's blood using an extracorporeal heat exchanger. These two 
methods have been used to reverse profound hypothermia, and therefore, could 
be used to attenuate the heat loss during surgery, but their use is neither practical 
nor risk-free. Both methods are fast and both can include dialysis of toxic 
substances from the blood. These advantages make their use more suited for an 
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emergency department than an operating room. Both have many inherent risks, 
and are, therefore, not useful in routine operating room circumstances (Fried et 
al., 1986; Harnett et al., 1983; Papenburg et al., 1987; Pickering et al., 1977). 
The final active method of preventing hypothermia concerns the warming of 
all fluids and blood products infused during surgery. This has been found to 
prevent and even reverse hypothermia, even in patients receiving 18 or more 
liters of fluid and blood over a few hours (Boyan & Howland, 1961, 1962, 1963; 
Buckhold et al., 1978; Copping et al., 1972). 
Effects of Blood Warming 
The deleterious effects of cold blood infusion were seemingly not 
appreciated until the mid 1950s. In 1955, Howland, Schweizer, Boyan, and Datto 
published a study concerning the physiologic alterations resulting from massive 
blood replacement. This study looked at two groups of patients who received 
multiple transfusions during the course of surgery. 
In group one (!! = 130), each patient received 10 or more units of citrated 
blood, and in group two (n = 123), each patient received 5-9 units of citrated 
whole blood. In group one, there was a 43% incidence of one of two major 
complications. The first complication concerned a defect in the clotting 
mechanism. This defect appeared to be directly related to the volume of blood 
administered. The second major complication involved the cessation of cardiac 
function in 22 patients, all of whom received more than 10 units of blood. In the 
11 patients monitored by electrocardiography, these cardiac dysfunctions were 
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identified as either ventricular fibrillation or asystole. The incidence of these 
dysfunctions appeared to be correlated not with the volume of blood 
administered, but with the speed of blood administration. It was concluded, "the 
exact mechanism by which rapid transfusion of large quantities of citrated blood 
produces either cardiac standstill or ventricular fibrillation is still in doubt ... " 
(Howland, Schweizer, Boyan, & Dotto, 1955). Hyperkalemia or citrate 
intoxication with resultant hypocalcemia was thought to play a role in the cardiac 
dysfunction. 
Interestingly, the authors stated "marked cooling of the viscera is a fact 
observed by many surgeons after massive blood replacement and is usually 
premonitory of impending disaster" (Howland et al., 1955). The authors also 
noted that a direct correlation between the degree of cooling and the onset of 
ventricular fibrillation appeared to exist. Cooling, however, was not listed as a 
possible major factor in the complications studied. 
In 1956, three of the same authors, Howland, Boyan, and Schweizer, 
examined ventricular fibrillation during massive blood replacement. In this study 
of 253 patients who received 2,500 ml or more of citrated banked blood, nine 
instances of ventricular fibrillation were noted. Six of these instances of 
ventricular fibrillation occurred in patients who had received more than 5,000 ml. 
The most consistent factor in the development of ventricular fibrillation was 
found to be rapid, intravenous, citrated blood replacement. It was concluded, 
however, that this rapid rate of administration was not the only factor responsible. 
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Other· possible factors contributing to cardiac dysrhythmias included 
hyperkalemia, citrate intoxication, pH of the blood, and, more importantly, 
hypothermia. The authors proposed that infusion of cold, banked blood resulted 
in a stream of cold blood being delivered directly to the right side of the heart 
and concluded "it is possible that this cooling of the myocardium may lead to 
cardiac arrhythmias and ventricular fibrillation" (Howland, Boyan, & Schweizer, 
1956). Also noted were classic alterations in the electrocardiogram which have 
since been associated with hypothermia such as peaked, elevated T waves, 
prolonged Q-T interval, and wide, bizarre QRS complexes. In conclusion, the 
authors speculated that lowered myocardial temperature may be one of the 
etiologic factors in the development of ventricular fibrillation. 
In 1961, Boyan and Howland examined the relationship between the 
temperature of administered blood, the patient's esophageal temperature, and 
physiological response. In this study, a thermocouple was inserted into the 
esophagus of patients to a point behind the right atrium to attain approximate 
cardiac temperatures. Two patients received 6,350 ml and 21,000 ml, respectively, 
of cold banked blood at 6,600-9,000 ml/hr and demonstrated progressive cardiac 
dysfunction. The first signs of cardiac change were noted at 29-33 ° C. These 
signs consisted of prolongation of the ST interval, bradycardia, ventricular 
extrasystoles, and hypotension. At 29.8-32 ° C all cardiac function ceased. 
Boyan and Howland (1961) reported the first clinical use of a blood 
warming apparatus. Three patients received 7,800-9,600 ml of 33-35 ° C blood 
through a blood warmer at a rate of 3,600 ml/hr. Temperatures for the three 
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patients remained above 35.7 • C and none exhibited signs of cardiac dysfunction. 
The authors concluded that cardiac difficulties associated with massive blood 
replacement could be related to the degree of hypothermia of the heart. 
All of the studies reviewed up to this point have been anecdotal or 
descriptive and have not provided statistical analyses nor specific methodologies. 
These researchers merely identified the occurrence of hypothermia as a result of 
cold, banked blood administration without utilizing true or quasi-experimental 
methodologies to validate their findings. 
In 1963, Boyan and Howland reported a retrospective, nonrandornized study 
of 81 patients who received 3,000 ml or more of blood, cold or warm, at rates of 
at least 3,000 ml/hr. Of the 36 patients who received cold blood, 25 had infusion 
rates of 3,000-6,000 ml/hr and 12 of these experienced cardiac arrest in the 
operating room. The remaining 11 patients received cold blood at greater than 
6,000 ml/hr and 9 experienced cardiac arrest in the operating room. There were 
45 patients who received blood via the warming device. Of these, 40 received 
blood at 3,000-6,000 ml/hr and none of these experienced cardiac arrests. The 
remaining five patients received warmed blood at rates exceeding 6,000 ml/hr 
and only one patient experienced a cardiac arrest in the operating room. 
The authors found a statistically significant (� = 29.0, 12 < .01) higher 
incidence of cardiac arrest in those patients receiving cold blood when compared 
to those receiving warm blood. A statistically significant (� = 20.4, 12 < .01) 
higher incidence of cardiac arrest was also found in patients receiving blood, 
warm or cold, at rates greater than 6,000 ml/hr as compared to those receiving 
blood at rates of 3,000-6,000 rnl/hr. The authors attributed part of these 
differences in the cardiac arrest incidence to the patient's condition since the 
patients who required rapid administration were most likely experiencing 
problems not controlled for in this retrospective study. 
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In 1964, Boyan reported on an additional number of patients who received 
blood via the blood warming device and statistically reexamined his 1963 study to 
include these patients. This study, as the first, was retrospective and 
nonrandomized. The same cold blood infusion group was used as before and 
more warm blood infusion patients were added to bring the total to 118 patients 
who received blood via the blood warming device. Once again a statistically 
significant difference (� = 44.5, 12. < .01) was found between the warm and cold 
groups with the patients receiving cold blood demonstrating a higher incidence of 
cardiac arrest in the operating room. A statistically significant difference 
(� = 35.7, 12. < .01) was also found between the patients receiving blood at 3,000-
6,000 ml/hr as compared to those receiving blood at greater than 6,000 ml/hr. 
As before, the faster infusion group demonstrated a higher incidence of cardiac 
arrest. All patients included since the previous study received blood via the 
blood warmer. No additional patients were infused cold blood. The author 
failed to discuss any changes in the patient population, criteria used for blood 
administration, surgical technique changes, or other factors that may have 
accounted for decreased morbidity and mortality. 
In 1986, Fried et al. reported on a rapid solution administration set (RSAS). 
This study described the in vivo use of the RSAS on one mongrel dog. The dog 
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was anesthetized, exsanguinated of 1,200 rnl of blood, and then administered the 
1,200 ml of autologous blood via the RSAS at 43,800 ml/hr. After 74 minutes, 
the dog was again exsanguinated of 1,200 ml of blood and then administered 
1,200 ml of 4 day old homologous blood via the RSAS at 42,600 ml/hr. 
Hemodynamic measurements, a battery of laboratory tests, and vital signs were 
recorded throughout the study period. 
Hemodynamic parameters, laboratory values, and vital signs were reported 
in a table without statistical analyses. On visual inspection, it appeared that post­
infusion values of all parameters measured were essentially the same as baseline 
measurements. The dog's temperature never fell more than 1.2 'C below its 
baseline temperature. The authors then concluded that this device is probably 
effective in maintaining normothermia in a trauma patient. This appeared to be 
a rather strong generalized conclusion from a study that (a) involved one mongrel 
dog, (b) made no statistical analysis, (c) involved no control group, and (d) made 
no mention of the setting where the study took place or to any control of other 
variables. For example, there was no mention of the ambient room temperature. 
Many studies have found ambient room temperature to be a significant 
contributor to maintenance of normothermia in surgical patients. 
Effects of CQ'stalloid Warmin� 
Newman (1971) reported a nonrandomized, controlled study of 33 patients 
receiving one of three interventions to prevent the development of hypothermia 
during surgery. Patients in Group I (Control group) were operated on without 
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any attempt to control their temperatures. Group II patients were placed on a 
warming blanket ( 40-42 ·C) throughout the operation, and Group III patients 
were placed on a warming blanket and given warmed (37 ·C) intravenous fluids 
and blood. Esophageal temperatures were measured every 15 minutes after 
induction of anesthesia. 
Fourteen of the 15 patients in Group I had a 2.0-4.6 • C decline in 
esophageal temperature. The remaining Group I patient had a 0.8 · C fall in 
temperature throughout the surgery. Seven of the eight Group II patients 
demonstrated a 0.5-2.0 • C decline in temperature during the surgery while the 
remaining patient had a 0.2 • C increase in temperature. The 10 patients in 
Group ill ranged from a 0.5 • C drop in esophageal temperature to a 1.3 • C gain 
in temperature. Visual examination of the data indicated that the warming 
blanket alone decreased the heat lost during surgery, and when combined with 
infusion of warm intravenous fluids, made the heat loss negligible. No definite 
conclusions can be reached, however, since no statistical analysis was reported. 
Copping et al. (1972) reported a nonrandomized, controlled study of 16 
mongrel dogs that were placed in controlled, hemorrhagic shock and subsequently 
volume repleted with lactated Ringer's solution at various temperatures. Group I 
(n = 5) received infusions of fluids cooled to 4.5 ·C. Group II (n = 6) served as 
a control group and received infusions of fluids at a room temperature of 21.0-
26.7 ·C. Group III (n = 5) received infusions of fluids warmed to 37.0 • C and 
infused at 33.3-34.4 ·C. All solutions were infused at 3,000 rnl/hr and all groups 
received similar volumes of intravenous fluid. Results of mortality rates, 
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esophageal temperatures, pulse changes, and ECG changes were presented, but 
analysis of data was confined to descriptive statistics. It appeared that the degree 
of hypothermia, cardiovascular changes, and mortality all increased as the 
infusion temperature decreased. While the study seemed to have controlled 
extraneous variables and demonstrated differences, it failed to provide statistical 
analyses to support any findings. 
Sumroacy 
As we have seen, the detrimental effects of rapid, cold blood administration 
has been recognized since the late 1950s. Since that time, various methods of 
warming blood have been investigated. Researchers then studied the effects of 
administering warmed intravenous fluids. From this line of research, it would 
appear that the use of various blood warming devices for warming both blood 
and crystalloid fluid plays a major role in decreasing both morbidity and mortality 
resulting from hypothermia. One new concept in fluid warming is the Thermal 
Jacket"'. Until now, no formal research has been done concerning its 
effectiveness in delivering warmed fluid. 
Chapter Two 
Review of Literature 
Methods of Warmin� Blood and Crystalloids 
A number of methods have been utilized in delivering warmed fluids and 
blood to the surgical patient. The first of these was first developed and reported 
in 1961 by Boyan and Howland. This blood warmer consisted of 24 feet of 4.5 
mm diameter plastic tubing wrapped around a wire frame and immersed in a 20 
liter water bath. The water in the bath was maintained near 37 · C by adding hot 
or cold water and was monitored using a bath thermometer. The one safety 
feature, a thermocouple, activated a warning light if the temperature in the bath 
exceeded 37 ·C. Though bulky and cumbersome to use, this first blood warmer 
was an improvement over cold blood administration. At flow rates of 3,000 
ml/hr this device warmed blood from a storage temperature of 4-6 • C to 35 ·C. 
The warmer was less efficient at flow rates of 6,000 ml/hr, warming the cold 
blood to 33 ·C. At higher flow rates of 7,200-9,000 ml/hr, the device was only 
able to warm the blood to 30.6-32 ·C. 
Baker (1985) investigated the effect of flow rate on heat loss in packed red 
blood cells warmed using a modern blood warmer (DUPACO, 
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Hemokinetitherm®) with a bath temperature maintained at 33-34 ·C. In an 
operating room with an uncontrolled ambient temperature measured at 16.2-
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18.7 • C, flow rates of the blood were manipulated over a range of 50-4,000 
ml/hr. Temperatures were measured at both the inlet and outlet ports of the 
blood warmer and again at the distal end of the infusion set. The blood used was 
initially near room temperature rather than at a typical storage temperature of 
4 • c. 
Baker ( 1985) found that at flow rates below 500 ml/hr, the delivered 
temperature of the blood was lower than the temperature at the inlet port of the 
blood warming unit. It was proposed that this heat loss may have been due to 
the colder temperature of the air near the floor, where the blood warmer was 
placed, and its effect on convective heat loss of the system. The use of the blood 
warmer at these flow rates may be counterproductive to the desired effect of 
delivering warmed fluids to the patient. At flow rates of 500-3,000 ml/hr there 
was a nonlinear, positive correlation between the flow rate and the delivered 
temperature of the blood indicating an ability to overcome convective heat losses 
that the slower flow rates experienced. Within this range, the faster flow rates 
resulted in higher delivered temperatures. At flow rates exceeding 3,000 ml/hr 
there was a steady decline in the delivered temperature. These flow rates, it was 
suggested, may have exceeded the heat transfer capabilities of the system used. 
Based on these findings, it was concluded that at flow rates between 500-3,000 
ml/hr the system was effective in increasing the delivered temperature of room 
temperature, banked blood. It was also concluded that outside of this flow rate 
range the system became ineffective and even counterproductive. 
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Cooter (1987) studied the Fenwal Dry Heat® blood warmer using a 
methodology similar to Baker's (1985), but with the following improvements: (a) 
the storage temperature of the blood was maintained at 1.2-4.3 ° C before 
infusion; and (b) the blood warming device used was mounted on a pole next to 
the patient potentially, eliminating the high convective loss near the floor of the 
operating room. Flow rates of 100-8,000 ml/hr were used and were compared to 
the delivered temperature. Additional infusion pumps were added to achieve 
higher flow rates. Uncontrolled room temperature was measured at 19.8-20.8 ° C. 
It was found that the delivered temperature of the blood rose continually 
from flow rates of 100 ml/hr to 1,000 ml/hr. There was a decline in the 
delivered temperature from flow rates of 1,100 ml/hr up to 1,900 ml/hr, and then 
another steady increase in delivered temperature at flow rates of 2,000-7,992 
ml/hr. Cooter concluded that the Fenwal Dry Heat® blood warmer became more 
effective as flow rates increased, and was more effective at high flow rates than 
the blood warmer used by Baker (1985). 
What Cooter (1987) did not address was the presence of variations in the 
expected delivered temperatures at several flow rates. For example, decline in 
delivered temperature from 1,100-2,000 ml/hr was noted, but not the peaks 
representing maximum differences from predicted temperatures at about 1,000, 
2,000, 3,000, 4,000, 5,000, 6,000, 7,000, and 8,000 ml/hr. On inspection, it 
appeared that these maximum differences occurred at flow rates corresponding to 
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the maximum output of these pumps or at points in the study when new pumps 
bad to be added to the system. The reason for addition of new pumps is that 
each Travenol volumetric infusion pump used was only capable of administering 
fluids up to 999 rnl/hr. As the experimental flow rate increased, it became 
necessary to connect additional pumps to accommodate this increase. 
Rymers (1988) studied a DUPACO, Hemokinetitherm® blood warmer 
similar to that investigated by Baker (1985). This study examined the effect of 
flow rate and intravenous tubing length on the delivered temperature of warmed 
packed, red blood cells. The heat loss at low flow rates in Baker's (1985) study 
was attributed to conductive losses caused by contact between the infusion tubing 
and cold surfaces in the study environment. Improving on the methodology used 
by Baker, Rymers ensured that no part of the infusion tubing carne in contact 
with any non-insulated object. With this modification, delivered temperatures 
were higher at all flow rates than temperatures at the inlet port of the blood 
warmer. The delivered temperature increased from flow rates of 100 rnl/hr to 
3,100 rnl/hr at which time a steady state was reached with similar delivered 
temperatures being attained up to 5,700 rnl/hr. Above this flow rate, a decline in 
delivered temperature was noted. It was also found that the greater the length of 
the infusion tubing, the more heat was lost between the blood warmer and the 
distal end of the infusion set. As with Cooter's (1987) study, Rymers' data 
showed fluctuations in the curve representing the relationship between flow rate 
and temperature at flow rates near the points where additional infusion pumps 
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had to be added. These fluctuations and relationships were not addressed in the 
discussion. 
Zorko and Polsky (1986) investigated yet another method of delivering 
warmed blood to the surgical patient. This study was designed to examine the 
flow rates of blood delivered at various temperatures and through various circuits. 
The delivered temperature of blood, stored at 4 ° C and divided into four 
research groups, was compared. In the control group (1), blood was infused 
through a blood administration set using no warming method. In a second group 
(II), stored blood was warmed using a Travenol blood warming coil and 
Hemokinetitherm® blood warmer. A third group (III) used the same infusion 
tubing as the control group, but in this group, 250 m1 of 45 ° C normal saline was 
added to the packed, red blood cells just prior to infusion. The fourth group (IV) 
combined both experimental methods (II & III) by adding warmed saline to the 
blood and infusing it through the blood warming device. 
It was pointed out that blood used in the control group was warmed to a 
mean temperature of 18 ° C as it traversed the length of the blood administration 
set. The addition of warmed saline to the blood resulted in a mean delivered 
temperature of 26 ° C. Infusion of cold blood through a blood warmer yielded a 
mean temperature of 29 ° C. The combination technique of adding warmed 
saline to the blood and infusing it through the warming device yielded the highest 
mean delivered temperature of 35.3 ° C. 
A number of possible problems exist in the methodology and conclusions. 
First, the units of blood in the control group (I) and in group II, which used the 
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blood warmer alone, were undiluted. Adding room temperature fluid to these 
groups, as was done with groups III and IV, would possibly have increased the 
initial blood temperatures above the stored temperature of 4 ° C. This would 
have, therefore, decreased the difference in delivered temperatures between the 
diluted and undiluted groups using the same method of delivery. Second, the 
control group gained 14 ° C without any intervention. An additional group, 
infusing unwarmed blood through a blood warming coil, but not using a blood 
warmer, may have determined how much of the temperature gain in the blood 
warming circuit was attributable to movement through the tubing exposed to 
ambient room temperature. A final major problem area with this study was the 
lack of flow rate control. Controlling the flow rate would have controlled the 
length of time the blood was exposed to ambient room temperature, and 
therefore determined the effect of room temperature exposure on delivered 
temperatures. Though the study was designed to examine flow rates, controlling 
the flow rates may have made the delivered temperature data more meaningful. 
Aldrete (1985) compared the delivered temperatures of lactated Ringer's 
solution infused at 6,000 ml/hr using one of three methods of warming the fluid. 
In Group 1, fluid was passed through a Goldman-Rupp blood warmer set at 
36 ° C using a 180 em intravenous tubing connected to the standard blood 
warming apparatus for a total length of 375 em. Fluids in Group 2 were warmed 
in a Sears Kenmore"' microwave oven to 41.5 ° C and delivered using only 180 em 
of tubing. Group 3 used a combination of these two methods. Group 4, the 
control group, consisted of room temperature fluid delivered through the 180 em 
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tubing using no warming methods. The control group maintained an approximate 
temperature of 18 • C both in the bag and at the distal infusion site. The 
unwarmed group using the blood warmer resulted in temperatures of 27 · C, 
while the combination method (microwave warming + blood warmer) increased 
the delivered temperature to 30 • C. The microwave warming alone, however, 
produced the highest delivered temperature of 33-34 • C. 
Aldrete (1985) also examined the temperature of fluids in the bag and 
delivered temperature of fluids at two flow rates. It was found that fluid in the 
bag and fluid delivered to the distal site both cooled more per volume infused 
when the infusion rate was 1,200 ml/hr as compared to an infusion rate of 6,000 
ml/hr. A possible problem with this finding is that the rate of cooling was not 
expressed in terms of time. It would appear logical that the length of time fluid 
is exposed to ambient room temperature could significantly effect the amount of 
heat lost in the fluid. Another possible shortcoming of this study was the lack of 
recorded specific temperatures. Very few temperatures were reported as exact 
values. Instead, most data was displayed in graphic form and showed only 
temperature trends. Though trends are informative, specific data could provide 
for statistical analysis. 
Another method of fluid warming was investigated by Fried et al. (1986). 
This study examined the efficiency of an extracorporeal heat exchanger when 
used as part of a rapid solution administration set. This set was designed to 
administer large amounts of fluid quickly through a 8.5 French catheter. With a 
countercurrent waterflow of 20 liters per minute at a temperature of 40 • C, blood 
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was warmed from a storage temperature of 4 · C to a delivered temperature of 
38-39 • C. There was a detailed explanation of the equipment and materials used 
to develop this administration set and a clear reporting of the findings. This 
study, however, used no control group and reported no statistical analysis of the 
data. 
Norman et al. (1986) studied the effects of flow rate, time, and insulation on 
the delivered temperature of lactated Ringer's solution prewarmed in a warming 
cabinet. It was found that the higher the initial temperature of the solution, the 
higher the delivered temperature at all time intervals. Fluids infused at 1,000 
ml/hr with an initial temperature of 44.0 • C had delivered temperatures of 
33.9 • C at 5 minutes and 28.0 • C at one hour after removal from the warming 
cabinet. At the same rate, fluids with an initial temperature of 49.6 • C bad 
delivered temperatures of 37.2 • C at 5 minutes and 31.0 • C at one hour. Fluids 
prewarmed to 50.0 • C and insulated using foam rubber as an insulating material 
bad a delivered temperature of 37.0 · C which was approximately the same as the 
uninsulated fluids. However, at one hour, the insulated fluid had a higher 
delivered temperature of 33.8 ·C. The control group maintained temperatures 
within 1 • C of ambient room temperature at all times measured. 
It was concluded that at a slower rate of 500 ml/hr, fluids had to be 
prewarmed to higher temperatures to have delivered temperatures approximating 
the higher infusion rate groups. Fluids prewarmed to 58.8 • C had delivered 
temperatures of 36.0 • C at 5 minutes and 30.1 ·C at 1 hour. With an initial 
temperature of 55.0 • C, the slower rate resulted in a delivered temperature of 
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28.9 • C at 1 hour. As a result, it was demonstrated that insulation of prewarmed 
bags of intravenous fluid helped maintain higher delivered temperatures 
throughout the one hour trial. It was also found that higher initial temperatures 
and higher flow rates resulted in higher delivered temperatures at all times 
studied. 
Sununazy 
The literature appears clear on the fact that administering cold intravenous 
fluid and blood can induce hypothermia in surgical patients. It also appears that 
delivering warm fluids and blood can decrease this incidence of hypothermia with 
its associated morbidity and mortality. A number of methods have been used to 
deliver warm fluids to the surgical patient. These methods can be grouped into 
(a) those devices or methods which warm the fluid en route to the patient, and 
(b) those methods or devices which warm the fluid prior to administration. In 
some instances, these methods have been combined with varying degrees of 
effectiveness. 
In all methods examined, there is an optimum delivery rate or range of rates 
at which the particular method is most effective. The slower infusion rates seem 
to be most susceptible to convective temperature loss from exposure to ambient 
room temperatures. This effect seems to be compounded when the infusion set is 
increased in length. Some studies find that prewarming fluids and delivering 
them through a short infusion set is the most effective means of delivering 
warmed fluids. Additionally, some find that insulating the fluid container 
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decreases the rate of heat loss and, therefore, increases the time the fluid can be 
administered at an effectively high temperature. 
A number of questions remain. First, how effective is insulation in 
maintaining the temperature of prewarmed fluids before administration? Second, 
what is the minimum flow rate at which fluids can be administered, using the 
various methods, to maintain an adequate delivered temperature? Third, is there 
a safe, inexpensive, and simple method of delivering fluids to a surgical patient at 
or near body temperature? 
Chapter Three 
Methodology 
Design 
To answer the question, is there a difference between the Thermal Jacket"' 
and conventional means in maintaining the delivered temperature of prewarmed 
crystalloid solutions at various flow rates in the operating room environment, a 
quasi-experimental design was used. The independent variables--flow rate and 
temperature maintenance device--were manipulated while the dependent variable­
-delivered temperature--was observed. Time was treated as a fixed variable. 
There were three experimental groups and one control group. In the control 
group, no temperature maintenance device was employed. 
Population and Sample 
The population consisted of all Thermal Jacket"' insulation devices and all 
Hemokinetitherm® fluid warmers. The Thermal Jacket"' used for this study was 
obtained from the manufacturer and the Hemokinetitherm® was obtained from an 
operating room currently using this warmer. The Thermal Jacket"' was a quilted, 
wrap-around, insulation device which enclosed bags of intravenous fluid and was 
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secured by Velcro straps. The Thermal Jacket"' depicted in Figure 1 appears in a 
closed configuration. 
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Figure 1. Thermal Jacket"' intravenous insulation device. 
Treatment Groups 
Group 1 was the control group. Intravenous (IV) fluids in this group were 
prewarmed and infused using no temperature maintenance device. 
Group 2 consisted of prewarmed IV fluids infused through a water bath type 
blood warmer. 
Group 3 consisted of IV fluids near 21 • C (ambient room temperature) and 
infused through a water bath type blood warmer. 
Group 4 consisted of prewarmed IV fluids infused using a Thermal Jacket'" 
insulation device. 
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Procedure 
Attempts were made to replicate a typical operating room environment with 
the exception of a patient and the surgical team. Doors to the operating room 
were closed, room lights were on, and surgical lamps were lit and focused on the 
center of the operating room table which was located at approximately the center 
of the room. Ambient room temperature was set at the wall thermostat to 21 ° C 
and measured throughout the study. All anesthesia equipment normally present 
in the room was turned on. 
The blood warmers were placed near the head of and on opposite sides of 
the operating table and were filled with sterile water to the manufacturer's 
specifications. A 30 minute equilibration time was allowed prior to data 
collection to allow stabilization of the water bath temperature. The bags of fluid 
were hung at 200 em from the floor and measures were taken to avoid contact 
between the bags, any part of the infusion sets, and other uninsulated surface or 
object. All infusion pumps were attached to IV poles 120 em from the floor with 
a minimum distance of 50 em between them. The infusion setup is depicted in 
Figure 2. 
One liter Viaflex'" (Fenwall Laboratories, Division of Travenol Laboratories, 
Incorporated, 1 Baxter Parkway, Deerfield, Illinois, 60015.) plastic containers of 
lactated Ringer's solution used for Groups 1, 2, and 4 were prewarmed to 
approximately 42 ° C by heating in a microwave oven set to maximum power for 
A Infusion set as used with Group 2 and Group 3. 
B. Infusion set as used with Group 1 and Group 4. 
IP. Infusion pump. 
BW. Hemokinetitherm® Blood Warmer. 
Tl. Temperature measurement site inside the bag of intravenous fluid. 
T2. Distal temperature measurement site. 
Figure 2. Infusion setup. 
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two minutes. The same type fluid was stored at room temperature and used for 
group 3. 
Identical standard intravenous pump tubing was used for all groups. Groups 
2 and 3 incorporated a blood warming coil attached to the distal end of the pump 
tubing and immersed in a preheated blood warmer according to the 
manufacturer's specifications. The intravenous pump tubing and blood warming 
coils were not modified from their normal length. The distal end of each infusion 
set was secured with tape to a piece of foam rubber on the operating table 90 em 
from the floor and allowed to drain into a collection container. 
After a baseline measurement, temperatures were recorded at 10 minute 
intervals over a 60 minute period at 2 different sites for each group. The first 
site measured was in the lower portion of the IV solution bag. This was 
accomplished by inserting a Mon-A-Therm® temperature probe through the 
rubber medication port in the bottom of the container. The second site was 2 em 
from the distal end of the infusion set and was measured using a Mon-A-Therm® 
inline thermistor. Temperatures were measured at flow rates of 100, 250, 500, 
750, and 1,000 ml/hr for each group. Room temperature was recorded at the 
same time intervals, and to decrease any variation that room temperature may 
have had, all groups were run simultaneously at each flow rate. 
Instrumentation 
Fluid Warmer. The DUPACO Hemokinetitherm® Model #32400 Fluid 
Warmer was used. It is an automatic system regulated by a proportional 
41 
controller which, according to the manufacturer, maintains a precise temperature 
in the 550 ml water reservoir between 33 ° C and 37 ° C for the flow rates used in 
this study. (DUPACO, Incorporated, 1740 LaCosta Meadows Drive, San Maras, 
California, 92069.) 
Blood Warmer Coil. A Fenwal Blood Warmer Coil with Extension Set 
(#4C2403) was used. Fluid was infused through the warming coil which was 
immersed in the water reservoir of the DUPACO Hemokinetitherm® in 
accordance with the manufacturer's instructions. The Fenwal coil measures 
approximately 535 em in total length and contains a volume of approximately 50 
ml. Of the 535 em, approximately 46 em of the tubing is proximal to the coil and 
174 em (extension set) is distal to the coil. (Fenwall Laboratories, Division of 
Travenol Laboratories, Incorporated, 1 Baxter Parkway, Deerfield, Illinois, 
60015.) 
Infusion Pump. The Travenol Flo-Gard Model 8000 volumetric infusion 
pump was used. The Flo-Gard 8000 delivered from 1 ml/hr to 999 ml/hr in 1 
ml/hr increments. It was accurate to ± 4 ml/hr at a setting of 125 ml/hr 
according to the manufacturer. (Travenol Laboratories, Incorporated, 1 Baxter 
Parkway, Deerfield, Illinois, 60015.) 
Volumetric Pump Solution Set. The Travenol Volumetric Pump Solution 
Set (#2C1031) was used. The set measured approximately 270 em in length and 
contained a volume of approximately 15 ml distal to the drip chamber. (Travenol 
Laboratories, Incorporated, 1 Baxter Parkway, Deerfield, Illinois, 60015.) 
42 
Temperature Monitorin� System. The Mon-A-Therm® Model 6500 
temperature monitoring system was used to measure temperatures at the two sites 
in the infusion setup and also to measure room temperature. The Mon-A­
Therm® is a two-channel, microprocessor-based, instrument which provides 
temperature measurements with a resolution of 0.1 ° C accurate to 0.1 ° C over a 
range of 1-50 ° C. It had a pre-set calibration which was checked each time the 
module was turned on. In this study, all temperature monitors used registered a 
calibration number of 100.0 ± 0.2 which indicated proper calibration according to 
the manufacturer's specifications. (Mon-A-Therm®, Incorporated, 520 South 
Jefferson Avenue, St. Louis, Missouri, 63103.) 
Temperature Monitorin� Probes. There were two types of temperature 
probes used in this study. A Mon-A-Therm®, 9 Fr., esophageal stethoscope with 
temperature sensor (Catalog #503-0032) was used to measure temperatures in 
the intravenous fluid containers. A Mon-A-Therm® luer lock temperature sensor 
(Catalog #503-0501) was used to measure delivered temperatures at the distal 
end of the infusion set. (Mon-A-Therm®, Incorporated, 520 South Jefferson 
Avenue, St. Louis, Missouri, 63103.) 
Data Analysis 
A two-way analysis of variance (ANOVA) was used to examine the effects 
of flow rate and the various methods of temperature maintenance on the 
delivered temperature of intravenous crystalloid solutions (group x flow rate). 
There were four levels of the group factor (Groups 1, 2, 3, 4) and five levels of 
the flow rate factor (100, 250, 500, 750, 1,000 ml/hr). 
Chapter Four 
Results 
A quasi-experimental design was used to determine the effect of the 
Thermal Jacket"', compared to conventional means, on the delivered temperature 
of prewarmed, crystalloid, intravenous solutions in the operating room 
environment. One control group and three experimental groups were used. 
Group 1 was the control group and consisted of prewarmed intravenous fluids 
infused using no temperature maintenance device. Group 2 consisted of 
prewarmed IV fluids infused through a water bath type blood warmer. Group 3 
consisted of IV fluids near ambient room temperature and infused through a 
water bath type blood warmer. Group 4 consisted of prewarmed IV fluids 
infused using a Thermal Jacket"' insulation device. 
Ambient room temperature was measured at 21.0 ± 0.2 ° C, but not 
controlled. Room temperature fluids were determined to be 22.05 ± 0.45 ° C and 
prewarmed fluid were heated to 41.45 ± 1.05 ° C. The mean temperatures of the 
fluid containers and the delivered temperatures for each group are shown in 
Table 1. The mean temperatures of both the fluid containers and the delivered 
temperatures for each flow rate are shown in Table 2. A Wilk's multifactor 
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Table 1 
Temperature of Fluids from Container 
to Distal Site by Group' 
Temperature (·C) 
Group 
1 
2 
3 
4 
Container 
36.7 ± 0.45 
37.3 ± 0.46 
21.9 ± 0.05 
39.9 ± 0.18 
· Mean Temperature ± S.E.M. 
Distal Site 
25.4 ± 0.54 
28.8 ± 0.61 
27.0 ± 0.52 
26.8 ± 0.65 
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Table 2 
Temperature of Fluids from Container 
to Distal Site by Flow Rate' 
Temperature (·C) 
Flow Rate 
(ml/hr) 
100 
250 
500 
750 
1,000 
Container 
33.6 ± 1.40 
34.4 ± 1.40 
33.8 ± 1.41 
34.0 ± 1.43 
33.8 ± 1.40 
· Mean Temperature ± S.E.M. 
Distal Site 
22.7 ± 0.43 
25.1 ± 0.39 
27.4 ± 0.53 
29.4 ± 0.46 
30.4 ± 0.42 
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analysis of variance revealed a highly significant overall group effect, .E( 6, 262) = 
150.59, p < .0001, as well as a highly significant flow rate effect, .E(8, 262) = 25.27, 
p < .0001, on the delivered temperature. 
Group Effect 
Analysis of variance showed a highly significant group effect on the 
delivered temperature. A Bonferroni multiple comparisons test was used to 
determine which groups were the major contributors. Group 2 had a significantly 
higher delivered temperature (12. < .05) than the other groups while Group 1 had a 
significantly lower delivered temperature (12. < .05). There was no statistically 
significant difference between the delivered temperatures of Group 2 and 
Group 3. 
Analysis of variance also showed a highly significant group effect on the 
temperature in the fluid container (12. < .05). A Bonferroni multiple comparisons 
test was used to determine which groups were the major contributors to this 
effect. Group 4 had a significantly higher temperature than the other groups 
(12. < .05) while Group 3 had a significantly lower temperature (12. < .05). There was 
no significant difference between the fluid container temperatures in Group 1 and 
Group 2. 
Flow Rate Effect 
Analysis of variance showed a highly significant flow rate effect. A 
Bonferroni multiple comparisons test was used to determine the relationship 
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between flow rate and the delivered temperature. A statistically significant 
(J;.?. < .05) difference was found between flow rates of 100, 250, 500, and 750 ml/hr, 
with the higher flow rates resulting in higher delivered temperatures. There was 
no significant difference, however, between flow rates of 750 and 1,000 ml/hr. 
Analysis of variance showed no significant difference between the fluid container 
temperatures at the various flow rates. 
Chapter Five 
Discussion 
The purpose of this quasi-experimental study was to determine the 
relationship between the flow rate and the delivered temperature of prewarmed, 
crystalloid, intravenous solutions when using the Thermal Jacketrw as compared to 
a conventional blood warming apparatus. 
Hypothesis Testing 
There were six hypotheses proposed in this study. They were as follows: 
1) there will be no difference between the delivered temperatures of 
prewarmed and room temperature fluids using a blood warmer apparatus; 
2) there will be no difference between the delivered temperatures of room 
temperature fluids using a blood warmer apparatus and prewarmed fluids using 
no temperature maintenance device; 
3) there will be no difference between the delivered temperatures of room 
temperature fluids using a blood warmer apparatus and prewarmed fluids using 
the Thermal Jacketrw; 
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4) there will be no difference between the delivered temperatures of 
prewarrned fluids using a blood warmer apparatus when compared with no 
temperature maintenance device; 
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5) there will be no difference between the delivered temperatures of 
prewarrned fluids using the Thermal Jacket"' when compared with no temperature 
maintenance device; and 
6) there will be no difference between the delivered temperatures of 
prewarrned fluids using the Thermal Jacket"' when compared with a blood 
warmer apparatus. 
Only one of these hypotheses failed to be rejected: there was no significant 
difference between the delivered temperatures of room temperature fluids passed 
through a blood warming device and prewarmed fluids using the Thermal Jacket" 
(Hypothesis 3). The remaining five hypotheses were rejected. There was a 
significant difference between the delivered temperatures when comparing the 
other group combinations. 
Correlation With Previous Studies 
This study supports the findings of Baker (1985), Cooter (1987), and Rymers 
(1988) that faster flow rates resulted in less heat loss and a higher delivered 
temperature. Unlike Baker's findings, at no time did the delivered temperature 
fall below the initial temperature of unwarmed fluid. One explanation for this 
could be the care taken in avoiding contact between the infusion tubing and any 
uninsulated surface. There were no unexplained temperature fluctuations in this 
study as in Cooter's and Ryrners' studies. Flow rates were not as high in this 
study, therefore, only one infusion pump was used for each group. 
This study also supported the findings of Norman et al. (1986). First, 
insulation of prewarmed fluids resulted in higher delivered temperatures than 
uninsulated fluids. Second, higher flow rates resulted in higher delivered 
temperatures due to a decrease in heat loss. 
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The delivered temperatures in this study did not match those of Boyan and 
Howland (1961). They reported delivered temperatures as high as 35 ° C at flow 
rates of 3,000 ml/hr. At a flow rate of 1,000 rnl/hr, room temperature fluid 
passing through the blood warmer reached a maximum temperature of 30.6 ° C. 
This discrepancy could be due to the flow rates or types of fluid compared. 
Boyan and Howland used banked blood, whereas, this study used crystalloid fluid. 
At slower flow rates, the warmed fluid is exposed to colder ambient room air 
longer and would tend to lose more heat. 
The results of this study differed from those of Aldrete (1985). Aldrete 
found that preheating, alone, resulted in the highest delivered temperature while 
the combination of preheating and blood warmer resulted in a still higher 
delivered temperature than the blood warmer alone. This study found that the 
combination of preheating and infusion through a blood warmer resulted in the 
highest delivered temperature. Infusing room temperature fluid through a blood 
warmer resulted in temperatures similar to the combination of preheating and 
using the Thermal Jacket"'. The obvious difference between the studies was the 
length of infusion tubing. In Aldrete's study the length of tubing distal to the 
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blood warmer was nearly the same length as the straight infusion set used. In the 
current study, the straight tubing was 96 em longer than the tubing distal to the 
blood warmer. As Rymers (1988) found, the length of tubing contributes 
significantly to the amount of heat loss. If the tubing lengths were identical, the 
results may have more closely correlated with Aldrete's. 
Aldrete also reported that the fluid in the container cooled more per 
volume infused at slower infusion rates. The problem of this reporting was 
pointed out previously, it did not account for the length of time the fluid was 
exposed to room air. In the current study, at slower infusion rates, there was a 
larger amount of heat lost per volume infused (0.086 ° C per ml at 100 ml/hr 
compared to 0.007 ° C at 1000 ml/hr) supporting the earlier criticism, there was 
no significant statistical correlation between infusion rates and temperature of 
fluid in the container in this study. 
Compared to Fried's (1986) study, the methods used in this investigation 
were far inferior in maintaining a warm delivery temperature. The difference was 
possibly related to the equipment used. Fried used an extracorporeal heat 
exchanger with a large countercurrent waterflow as the heat source. This was a 
much more elaborate and expensive setup, and was designed as a rapid solution 
administration set for use with mass trauma cases. The methods used in the 
current study correspond to more widely used operating room techniques. 
Flow Rate Effect 
There was a highly significant correlation between flow rate and the 
delivered temperature. Higher flow rates resulted in higher delivered 
temperatures due, at least in part, to the time the fluid was exposed to the 
relatively cooler, ambient room air. There was an insignificant correlation 
between flow rate and the temperature of the fluid in the container. 
Group Effect 
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There was a highly significant difference between the various groups in 
maintaining the temperature of the fluid in the container as well as the delivered 
temperature. The Thermal Jacket'" provided insulation and maintained a higher 
temperature of the fluid in the container. The combination of prewarming and 
delivery through a blood warmer resulted in higher delivered temperatures at all 
flow rates. Prewarming fluids and insulating with the Thermal Jacket'" provided 
delivery temperatures similar to those of infusing room temperature fluids 
through a blood warmer and through a conspicuously shorter length of tubing. 
Prewarrning and infusing through a straight infusion set resulted in the lowest 
delivered temperatures. 
Limitations 
The only serious limitation to this study was the length of tubing used with 
the various groups. The tubing lengths were chosen to resemble, as closely as 
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possible, the clinical situation in which these methods of warming fluids might be 
utilized. Various blood warmers have differences in their effectiveness in 
warming fluids over a range of flow rates. This, combined with the broad range 
of temperatures at which the fluid can be prewarmed, varying ambient room 
temperatures, and combinations of other heat-maintenance maneuvers, limits the 
generalizability of this study. 
Recommendations for Further Study 
The study should be repeated with the following modifications: 
1) Alter the length of the infusion tubing of the straight infusion set to 
match that distal to the blood warmer. 
2) Vary room temperature to both extremes to quantify the room 
temperature effect on heat loss. 
3) Manipulate the flow rates over a larger range. 
4) Insulate the infusion tubing to further decrease heat loss to ambient 
room air. 
The Thermal Jacket"' should also be investigated in the clinical setting. 
Patients could be divided into 3 groups. One group could have room 
temperature fluids infused throughout their surgery. Another group could have 
fluids delivered via a conventional blood warming device. A third group could 
have fluids prewarmed and delivered using the Thermal Jacket"'. 
Conclusion 
In the setting studied, the Thermal Jacket"' was an effective means of 
delivering prewarmed, crystalloid, intravenous fluid via a straight infusion set. 
54 
This could be an advantage in situations where a blood warming device may not 
be available or the high resistance to flow in the blood warming coil may impede 
administration of fluids at desired flow rates. Though using the blood warmer 
with prewarmed fluids was more effective in this study, this difference may be 
reduced by shortening the length of intravenous tubing used in conjunction with 
the Thermal Jacket"'. Additional studies of the Thermal Jacket"', as outlined, may 
clarify the advantages of each method. 
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